5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.67%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-79.85%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
59.38%
EBIT growth similar to METSB.HE's 59.38%. Walter Schloss might infer both firms share similar operational efficiencies.
59.38%
Operating income growth similar to METSB.HE's 59.38%. Walter Schloss would assume both share comparable operational structures.
44.07%
Net income growth comparable to METSB.HE's 44.07%. Walter Schloss might see both following similar market or cost trajectories.
35.29%
EPS growth similar to METSB.HE's 35.29%. Walter Schloss would assume both have parallel share structures and profit trends.
35.29%
Similar diluted EPS growth to METSB.HE's 35.29%. Walter Schloss might see standard sector or cyclical influences on both firms.
-13.56%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-13.56%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
5.88%
Similar OCF growth to METSB.HE's 5.88%. Walter Schloss would assume comparable operations or industry factors.
107.14%
FCF growth similar to METSB.HE's 107.14%. Walter Schloss would attribute it to parallel capital spending and operational models.
5.21%
Similar 10Y revenue/share CAGR to METSB.HE's 5.21%. Walter Schloss might see both firms benefiting from the same long-term demand.
5.21%
5Y revenue/share CAGR similar to METSB.HE's 5.21%. Walter Schloss might see both companies benefiting from the same mid-term trends.
5.21%
3Y revenue/share CAGR similar to METSB.HE's 5.21%. Walter Schloss would assume both companies experience comparable short-term cycles.
-71.64%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-71.64%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-71.64%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
54.17%
Similar net income/share CAGR to METSB.HE's 54.17%. Walter Schloss would see parallel tailwinds or expansions for both firms.
54.17%
5Y net income/share CAGR similar to METSB.HE's 54.17%. Walter Schloss might see both on parallel mid-term trajectories.
54.17%
3Y net income/share CAGR similar to METSB.HE's 54.17%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.39%
Inventory growth well above METSB.HE's 2.39%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.21%
Similar asset growth to METSB.HE's 0.21%. Walter Schloss finds parallel expansions or investment rates.
11.60%
Similar to METSB.HE's 11.60%. Walter Schloss finds parallel capital usage or profit distribution strategies.
3.40%
Debt growth far above METSB.HE's 3.40%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.